Eric Coldwell
Stock Analyst at Baird
(5.00)
# 10
Out of 4,876 analysts
193
Total ratings
56.48%
Success rate
129.68%
Average return
Main Sectors:
Stocks Rated by Eric Coldwell
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMI Owens & Minor | Maintains: Neutral | $9 → $10 | $8.33 | +20.05% | 18 | Jun 6, 2025 | |
| PINC Premier | Maintains: Neutral | $19 → $22 | $21.80 | +0.92% | 8 | May 15, 2025 | |
| CRL Charles River Laboratories International | Maintains: Neutral | $118 → $140 | $151.59 | -7.65% | 14 | May 8, 2025 | |
| IQV IQVIA Holdings | Maintains: Neutral | $195 → $161 | $158.16 | +1.80% | 17 | May 7, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Neutral | $192 → $160 | $146.75 | +9.03% | 20 | May 2, 2025 | |
| CAH Cardinal Health | Maintains: Outperform | $156 → $170 | $165.61 | +2.65% | 12 | May 2, 2025 | |
| LH Labcorp Holdings | Maintains: Outperform | $253 → $267 | $256.98 | +3.90% | 13 | Apr 30, 2025 | |
| MEDP Medpace Holdings | Maintains: Neutral | $340 → $313 | $306.80 | +2.02% | 18 | Apr 23, 2025 | |
| DGX Quest Diagnostics | Maintains: Outperform | $191 → $194 | $177.06 | +9.57% | 10 | Apr 23, 2025 | |
| AHCO AdaptHealth | Maintains: Outperform | $14 → $16 | $9.42 | +69.85% | 10 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $28 → $25 | $5.20 | +380.77% | 7 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $531 → $688 | $722.00 | -4.71% | 17 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $51 | $11.38 | +348.15% | 16 | Apr 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $35 → $45 | $61.99 | -27.41% | 2 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $62 → $66 | $68.14 | -3.14% | 7 | May 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $67 → $46 | $1.48 | +3,008.11% | 4 | Nov 10, 2017 |
Owens & Minor
Jun 6, 2025
Maintains: Neutral
Price Target: $9 → $10
Current: $8.33
Upside: +20.05%
Premier
May 15, 2025
Maintains: Neutral
Price Target: $19 → $22
Current: $21.80
Upside: +0.92%
Charles River Laboratories International
May 8, 2025
Maintains: Neutral
Price Target: $118 → $140
Current: $151.59
Upside: -7.65%
IQVIA Holdings
May 7, 2025
Maintains: Neutral
Price Target: $195 → $161
Current: $158.16
Upside: +1.80%
ICON Public Limited Company
May 2, 2025
Maintains: Neutral
Price Target: $192 → $160
Current: $146.75
Upside: +9.03%
Cardinal Health
May 2, 2025
Maintains: Outperform
Price Target: $156 → $170
Current: $165.61
Upside: +2.65%
Labcorp Holdings
Apr 30, 2025
Maintains: Outperform
Price Target: $253 → $267
Current: $256.98
Upside: +3.90%
Medpace Holdings
Apr 23, 2025
Maintains: Neutral
Price Target: $340 → $313
Current: $306.80
Upside: +2.02%
Quest Diagnostics
Apr 23, 2025
Maintains: Outperform
Price Target: $191 → $194
Current: $177.06
Upside: +9.57%
AdaptHealth
Feb 27, 2025
Maintains: Outperform
Price Target: $14 → $16
Current: $9.42
Upside: +69.85%
Dec 6, 2024
Downgrades: Neutral
Price Target: $28 → $25
Current: $5.20
Upside: +380.77%
Nov 7, 2024
Upgrades: Outperform
Price Target: $531 → $688
Current: $722.00
Upside: -4.71%
Apr 1, 2022
Downgrades: Neutral
Price Target: $51
Current: $11.38
Upside: +348.15%
Jun 26, 2020
Maintains: Neutral
Price Target: $35 → $45
Current: $61.99
Upside: -27.41%
May 7, 2020
Maintains: Neutral
Price Target: $62 → $66
Current: $68.14
Upside: -3.14%
Nov 10, 2017
Maintains: Outperform
Price Target: $67 → $46
Current: $1.48
Upside: +3,008.11%